
Keywords: lymphoma; primary cutaneous B-cell lymphoma; primary cutaneous diffuse large B-cell lymphoma; primary cutaneous follicle center lymphoma; primary cutaneous marginal zone lymphoma; rituximab; therapy; CBCL; cutaneous B-cell lymphoma; CHOP; cyclophosphamide